| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 598.500 +10.11% on 02/26/26 | | 867.000 -23.99% on 02/11/26 | -167.000 (-20.22%) since 02/04/26 |
| 3-Month | 566.303 +16.37% on 12/22/25 | | 952.000 -30.78% on 01/16/26 | +40.000 (+6.46%) since 12/04/25 |
| 52-Week | 232.500 +183.44% on 04/09/25 | | 952.000 -30.78% on 01/16/26 | +364.000 (+123.39%) since 03/04/25 |
Oxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T Therapy Oxford, UK – 26 July 2022: Oxford...
Oxford Biomedica initiates new project with Orchard Therapeutics utilising LentiStable™ technology Oxford, UK – 26 July 2022: Oxford Biomedica plc...
Oxford Biomedica plcPreliminary results for the year ended 31 December 2021 Saving Lives Oxford, UK – 20 April 2022: Oxford Biomedica plc (LSE: OXB),...
Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customers Oxford, UK –...
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the successful...
Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific Officer ABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12,...
| 3rd Resistance Point | 715.000 |
| 2nd Resistance Point | 687.000 |
| 1st Resistance Point | 673.000 |
| Last Price | 659.000 |
| 1st Support Level | 631.000 |
| 2nd Support Level | 603.000 |
| 3rd Support Level | 589.000 |
| 52-Week High | 952.000 |
| Fibonacci 61.8% | 677.151 |
| Last Price | 659.000 |
| Fibonacci 50% | 592.250 |
| Fibonacci 38.2% | 507.349 |
| 52-Week Low | 232.500 |